Showing results (61-70 of 152) with videos related to

Sort By:
Pageof 16
Der Nervenarzt|March 18, 2017
[Genetic tests for controlling treatment with antidepressants]T Bschor, C Baethge, C Hiemke, et al.
The Journal of Endocrinology|September 1, 1985
Time-dependent effects of oestradiol and progesterone on hypothalamic catecholamine turnover in ovariectomized ratsC Hiemke, D Bruder, M C Michel, et al.
Pharmacopsychiatry|December 1, 1998
Serum concentrations of fluvoxamine and clinical effects. A prospective open clinical trialS Härtter, H Wetzel, E Hammes, et al.
Psychopharmacology|May 1, 1997
Doxepin and its metabolites in plasma and cerebrospinal fluid in depressed patientsM Deuschle, S Härtter, C Hiemke, et al.
Clinical Pharmacology and Therapeutics|February 11, 2000
Increased bioavailability of oral melatonin after fluvoxamine coadministrationS Härtter, M Grözinger, H Weigmann, et al.
Pharmacogenetics|January 16, 1998
CYP2D6 genotype and phenotyping by determination of dextromethorphan and metabolites in serum of healthy controls and of patients under psychotropic medicationD Köhler, S Härtter, K Fuchs, et al.
Therapeutic Drug Monitoring|August 26, 1998
Nonlinear pharmacokinetics of fluvoxamine and gender differencesS Härtter, H Wetzel, E Hammes, et al.
Therapeutic Drug Monitoring|June 1, 1996
Automated determination of dextromethorphan and its main metabolites in human plasma by high-performance liquid chromatography and column switchingS Härtter, D Baier, J Dingemanse, et al.
Pharmacopsychiatry|March 30, 2004
Reduction of clozapine-induced hypersalivation by pirenzepine is safeB Schneider, H Weigmann, C Hiemke, et al.
Der Nervenarzt|December 19, 2013
[Therapeutic drug monitoring in psychiatry. A brief summary of the new consensus paper by the task force on TDM of the AGNP]G Gründer, P Baumann, A Conca, et al.
Pageof 16